Xiaoqing Yu

16PUBLICATIONS
176CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMedical molecular engineering of nucleic acids and proteinsBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

|May 21, 2026
A MAFG~MITF complex drives melanoma phenotype switching and progression.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Feb 09, 2026
A Multistep Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma.

Xiaonan Xu, Xiaoxian Liu, Vinesh Jarajapu

|Jan 13, 2026
CGPA: A Multicontext Cancer Gene Prognosis Atlas.

Biwei Cao, Xiaoqing Yu, Guillermo Gonzalez

Pageof 3

Frequent Collaborators

4 joint publications

Kenneth Y Tsai

4 joint publications

Paulo C Rodriguez

3 joint publications

Xuefeng Wang

3 joint publications

Steven Eschrich